Skip to content
Disclosery

VHCP Management, LLC

Follow

13F filer, CIK 1479355, NEW YORK, NY

VHCP Management, LLC reported $390,060,000 across 18 holdings for the quarter ended 2015-09-30, in a 13F-HR filed 2015-11-13. Its ten largest share positions make up 86.28% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-15-011918

Period
2015-09-30
Reported value
$390M
Holdings
18
Top 10 weight
86.28%
New
3
Sold out
3

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RGNXnew+1,083,454$20.2M
AKARI THERAPEUTICS PLCnew+527,842$12.7M
Sierra Oncology, Inc.new+250,000$5.13M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ARCA biopharma Increduced-9,247,993-$45.9M
BCRXexited-373,686-$5.58M
ZS PHARMA INCexited-100,000-$5.24M
JUNO THERAPEUTICS INCexited-90,206-$4.81M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2015

Share positions as resolved from 13F-HR 0000950123-15-011918, largest first. % of portfolio is the value over $390,060,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ANACOR PHARMACEUTICALS INCANACOR PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,178,474 shares; 2015Q2: 1,178,474 shares; 2015Q3: 1,178,474 shares 1,178,474$139M35.56%0
DBV TechnologiesDBV TechnologiesQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 693,810 shares; 2015Q2: 693,810 shares; 2015Q3: 693,810 shares 693,810$45.6M11.69%0
GW PHARMACEUTICALS PLCGW PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 311,853 shares; 2015Q2: 311,853 shares; 2015Q3: 311,853 shares 311,853$28.5M7.31%0
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,095,734 shares; 2015Q2: 1,095,734 shares; 2015Q3: 1,095,734 shares 1,095,734$26.7M6.85%0Timeline
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 1,083,454 shares 1,083,454$20.2M5.17%newTimeline
CHRSCOHERUS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 870,269 shares; 2015Q2: 870,269 shares; 2015Q3: 870,269 shares 870,269$17.4M4.47%0Timeline
ZAFGEN INCZAFGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 541,480 shares; 2015Q2: 541,480 shares; 2015Q3: 541,480 shares 541,480$17.3M4.44%0
LIPOCINE INC NEWLIPOCINE INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 669,921 shares; 2015Q2: 1,269,921 shares; 2015Q3: 1,269,921 shares 1,269,921$15M3.85%0
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 811,152 shares; 2015Q2: 811,152 shares; 2015Q3: 811,152 shares 811,152$14.4M3.68%0Timeline
AKARI THERAPEUTICS PLCAKARI THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 527,842 shares 527,842$12.7M3.25%new
AVALANCHE BIOTAVALANCHE BIOTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,382,735 shares; 2015Q2: 1,382,735 shares; 2015Q3: 1,382,735 shares 1,382,735$11.4M2.92%0
Alcobra LtdAlcobra LtdQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,500,000 shares; 2015Q2: 1,500,000 shares; 2015Q3: 1,500,000 shares 1,500,000$9.06M2.32%0
FLAMEL TECHNOLOGIES-SP ADRFLAMEL TECHNOLOGIES-SP ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 500,000 shares; 2015Q2: 500,000 shares; 2015Q3: 500,000 shares 500,000$8.15M2.09%0
ARCA biopharma IncARCA biopharma IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: 10,789,324 shares; 2015Q3: 1,541,331 shares 1,541,331$7.64M1.96%-9,247,993
Cynapsus Therapeutics IncCynapsus Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 5,878,855 shares; 2015Q2: 367,427 shares; 2015Q3: 367,427 shares 367,427$5.94M1.52%0
Sierra Oncology, Inc.Sierra Oncology, Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 250,000 shares 250,000$5.13M1.32%new
STEMLINE THERAPEUTICS INCSTEMLINE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 451,400 shares; 2015Q2: 451,400 shares; 2015Q3: 451,400 shares 451,400$3.99M1.02%0
OCERA THERAPEUTICS INC COMOCERA THERAPEUTICS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 703,730 shares; 2015Q2: 703,730 shares; 2015Q3: 703,730 shares 703,730$2.22M0.57%0

Sold out in Q3 2015

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
BCRXBIOCRYST PHARMACEUTICALS INC373,686$5.58Mshares
ZS PHARMA INCZS PHARMA INC100,000$5.24Mshares
JUNO THERAPEUTICS INCJUNO THERAPEUTICS INC90,206$4.81Mshares

How Q3 2015 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-15-011918 base2015-11-13acceptance time not in the bulk data set